Found: 17
Select item for more details and to access through your institution.
Mycobacterium gordonae-induced humidifier lung.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Eosinophil transendothelial migration induced by the bronchoalveolar lavage fluid of acute eosinophilic pneumonia.
- Published in:
- Respirology, 2017, v. 22, n. 5, p. 913, doi. 10.1111/resp.12982
- By:
- Publication type:
- Article
Establishing a whole blood CD4<sup>+</sup> T cell immunity measurement to predict response to anti-PD-1.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10445-2
- By:
- Publication type:
- Article
Establishing a whole blood CD4<sup>+</sup> T cell immunity measurement to predict response to anti-PD-1.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10445-2
- By:
- Publication type:
- Article
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
- Published in:
- Oncology, 2024, v. 102, n. 1, p. 30, doi. 10.1159/000533604
- By:
- Publication type:
- Article
Effect of Formoterol on Eosinophil Trans-Basement Membrane Migration Induced by Interleukin-8-Stimulated Neutrophils.
- Published in:
- International Archives of Allergy & Immunology, 2013, v. 161, p. 10, doi. 10.1159/000350335
- By:
- Publication type:
- Article
Omalizumab Attenuates Airway Inflammation and Interleukin-5 Production by Mononuclear Cells in Patients with Severe Allergic Asthma.
- Published in:
- International Archives of Allergy & Immunology, 2013, v. 161, p. 107, doi. 10.1159/000350852
- By:
- Publication type:
- Article
Changes in Airway Inflammation and Hyperresponsiveness after Inhaled Corticosteroid Cessation in Allergic Asthma.
- Published in:
- International Archives of Allergy & Immunology, 2010, v. 152, p. 41, doi. 10.1159/000312124
- By:
- Publication type:
- Article
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 5, p. 1280, doi. 10.1111/1759-7714.13394
- By:
- Publication type:
- Article
Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non‐small cell lung cancer harboring EGFR mutation.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1045, doi. 10.1111/1759-7714.13363
- By:
- Publication type:
- Article
Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 992, doi. 10.1111/1759-7714.13044
- By:
- Publication type:
- Article
Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies in lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 975, doi. 10.1111/1759-7714.13039
- By:
- Publication type:
- Article
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 775, doi. 10.1111/1759-7714.12998
- By:
- Publication type:
- Article
Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Combination of immune check inhibitor and immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: A case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study